WCIT-2013 provides an ideal platform to showcase your novel technologies and products in China. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the poster sessions will also take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at WCIT-2013
To meet face-to-face with the international movers and shakers in the field of Medicinal Chemistry
To Meet with Key Decision Marker around the World
To Explore Business Opportunities in China and beyond
To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall
Sponsorship Opportunity
The conference invites your organization to join other industry and academic leaders to be a sponsor of our events.
We design kinds of sponsorship opportunities, which will provide your organization with an exceptional level of exposure for your products and services and also build relationships with universities, schools, companies and experts from all around the world. We can also work with you to tailor our sponsorship packages to maximize the value of the sponsorship to your circumstances.
BIT’s 3rd Annual World Vaccine Congress-2012(WCIT-2012) was jointly held with the 4th Annual Protein and Peptide Conference, the 3rd Annual World Congress of BioSoft as well as the 3rd Annual Congress of Antibodies in Beijing which have attracted more than 1500 participants and 48 exhibitors from 56 countries have joined the conference and made the best out of it. More...
Scenery of Tour
The Walls of Badaling
Terra Cotta Warriors and Horses
Tibet
The Forbidden City
Hua Qing Hot Spring
Suzhou Garden
We welcome you to visit the tour webpage to learn more about the routes and prices. To join a tour please contact : muriel@bitworldtravel.com
China Council for the Promotion of
International Trade
Dalian Sub-Council
Organization List
Sanofi Pasteur Inc., France
GlaxoSmithKline Biologicals, Belgium
Abbott Biologicals, The Netherlands
Crucell, The Netherlands
MedImmune, Inc., USA
Quintiles Transnational Corporation, USA
GE Healthcare, Sweden
Immunovaccine Inc., USA
Arbovax, Inc., USA
Transgene S.A., France
Drug Safety Solutions Ltd., USA
Bill & Melinda Gates Foundation, USA
The International Society for Vaccines, UK
The U.S. Food and Drug Administration, USA
PATH, USA
World Health Organization, Indonesia
International Medica Foundation, USA
The Brighton Collaboration, Switzerland
National Cancer Institute, USA
Sabin Vaccine Institute, USA
Institute Pasteur, France
Noetic Advanced Studies Institute, USA
Queensland Institute of Medical Research, Australia
Johns Hopkins Medical Institutions, USA
University of Illinois, USA
University of California, Los Angeles, USA
University of Alberta, Canada
Oxford University, UK
The Ohio State University, USA
Harvard School of Public Health, USA
University of Technology Sydney, Australia
University of Georgia, USA
Monash University, Australia
University of Miami, USA
Clear Springs Foods Inc., USA
University of Pittsburgh, USA
University of Toronto, Canada
State University of New York, Stony Brook, USA
University of North Carolina at Chapel Hill, USA
University of Saskatchewan, Canada
University of Veterinary Medicine, Austria
Braasch Biotech LLC, USA
CureVac GmbH, Germany
Global Pharma Tek, USA
Datamonitor, USA
Biological Mimetics, Inc., USA
Biologics R&D, Merial Limited, USA
Germinder Associates, Inc., USA
PHARMAQ Vietnam Co. Ltd, Norway
Microgen State Company, Russia
Immune Targeting Systems (ITS) Ltd., UK
AVIR Green Hills Biotechnology AG, Austria
NNE Pharmaplan, Denmark
Celgene Corporation, USA
Asia Pacific & China, BIA Separations, Austria
Singapore Immunology Network, Singapore